PHARMALEX
ActiveSummary
PHARMALEX has been active since 2000 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.9m and a net result of €64,882. Equity remains stable across the filed fiscal years (±2.3% per year). Its solvency ranks better than 88% of 1007 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
This company filed its last 7 accounts on average 45 days before the deadline; the sector median for financial year 2024 is 9 days before the deadline, and 32% of the sector filed late.
Checked, nothing found (2)
History
Go further with this company
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, full schema
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 69, Legal and accounting activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
- 2024 Net result -53% on 2023. The accounts now follow the full schema, last year the abbreviated schema.
- 2023 Net result +109% on 2022. The previous fiscal year ran 6 months, this one 12. The accounts now follow the abbreviated schema, last year the full schema.
- 2022 Net result -75% on 2021. This fiscal year ran 6 months, the previous one 12.
Peer companies
Historical observationOf the 14,684 companies that looked in July 2024 the way this one looks now, 0.2% went bankrupt within 24 months and 96% are still going.
- Small
- 20 years or older
- solvency 30% or more
- a profit under 5% of the balance sheet
A further 0.2% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.6% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 14,684 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Turnover70 | - | - | €1.9m | - | - | - |
| Goods, raw materials, services and sundry goods60/61 | - | - | €640,802 | - | - | - |
| Remuneration, social security and pensions62 | - | €358,515 | €754,854 | €960,238 | €1.1m | ▲ 10.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €454 | €227 | €484 | €1,512 | €1,548 | ▲ 2.4% |
| Other operating charges640/8 | - | €36 | €1,080 | €975 | €6,112 | ▲ 527% |
| Non-recurring operating charges66A | - | - | - | - | €3,000 | - |
| Gross operating margin9900 | €1.5m | €595,958 | €1.2m | €1.2m | €1.2m | ▼ 4.9% |
| Operating profit (loss)9901 | €914,870 | €237,180 | €477,599 | €252,832 | €88,406 | ▼ 65.0% |
| Financial income75/76B | - | €2,156 | €9,515 | €8,045 | €13,345 | ▲ 65.9% |
| Recurring financial income75 | €62,308 | €2,156 | €9,515 | €8,045 | €13,345 | ▲ 65.9% |
| Financial charges65/66B | - | €665 | €1,447 | €4,693 | €2,790 | ▼ 40.6% |
| Recurring financial charges65 | €28,568 | €665 | €1,447 | €4,693 | €2,790 | ▼ 40.6% |
| Profit (loss) for the period before taxes9903 | €948,014 | €238,672 | €485,667 | €256,183 | €98,961 | ▼ 61.4% |
| Income taxes67/77 | €242,359 | €62,096 | €116,848 | €82,028 | €34,079 | ▼ 58.5% |
| Profit (loss) for the period9904 | €705,655 | €176,576 | €368,819 | €174,155 | €64,882 | ▼ 62.7% |
| Transfer from tax-exempt reserves789 | - | €44,500 | €101,040 | €89,000 | - | - |
| Transfer to tax-exempt reserves689 | - | - | €63,150 | €63,150 | €33,107 | ▼ 47.6% |
| Profit (loss) for the period to be appropriated9905 | €767,655 | €221,076 | €406,709 | €200,005 | €31,775 | ▼ 84.1% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €2.9m | €2.4m | €2.6m | €2.5m | €2.3m | ▼ 10.0% |
| Fixed assets21/28 | €499 | €800,272 | €806,206 | €7,338 | €5,790 | ▼ 21.1% |
| Tangible fixed assets22/27 | €499 | €272 | €6,206 | €7,338 | €5,790 | ▼ 21.1% |
| Plant, machinery and equipment23 | - | - | - | €2,415 | €2,151 | ▼ 10.9% |
| Furniture and vehicles24 | - | €272 | €6,206 | €4,923 | €3,639 | ▼ 26.1% |
| Financial fixed assets28 | - | €800,000 | €800,000 | - | - | - |
| Current assets29/58 | €2.9m | €1.6m | €1.8m | €2.5m | €2.3m | ▼ 9.9% |
| Amounts receivable within one year40/41 | €584,901 | €780,443 | €1.3m | €2.2m | €1.8m | ▼ 17.2% |
| Trade receivables40 | - | €735,640 | €747,873 | €939,768 | €628,309 | ▼ 33.1% |
| Other amounts receivable41 | - | €44,803 | €582,528 | €1.2m | €1.2m | ▼ 5.2% |
| Cash at bank and in hand54/58 | €2.3m | €774,627 | €406,925 | €322,352 | €431,662 | ▲ 33.9% |
| Deferred charges and accrued income490/1 | - | €16,679 | €15,935 | €14,004 | €30,369 | ▲ 117% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €2.9m | €2.4m | €2.6m | €2.5m | €2.3m | ▼ 10.0% |
| Equity10/15 | €1.9m | €1.9m | - | €1.9m | €1.9m | ▲ 1.0% |
| Contributions10/11 | - | €18,600 | €18,600 | €18,600 | €18,600 | = |
| Reserves13 | €1.9m | €1.9m | €1.9m | €1.9m | €1.9m | ▲ 1.8% |
| Non-distributable reserves130/1 | - | €800,000 | €800,000 | €800,000 | €800,000 | = |
| Reserves not available under the articles1311 | - | - | €800,000 | €800,000 | €800,000 | = |
| Financial assistance1313 | - | €800,000 | - | - | - | - |
| Tax-exempt reserves132 | - | €190,040 | €152,150 | €126,300 | €159,407 | ▲ 26.2% |
| Distributable reserves133 | - | €891,360 | €992,400 | €931,400 | €931,400 | = |
| Profit (loss) carried forward14 | €21,443 | €177 | €2,808 | €20,794 | €7,065 | ▼ 66.0% |
| Amounts payable17/49 | €942,415 | €471,844 | €593,509 | €626,802 | €356,010 | ▼ 43.2% |
| Amounts payable within one year42/48 | €940,888 | €465,591 | €593,509 | €626,802 | €356,010 | ▼ 43.2% |
| Trade debts44 | €66,974 | €136,545 | €160,183 | €240,640 | €107,734 | ▼ 55.2% |
| Suppliers440/4 | - | €136,545 | €160,183 | €240,132 | €107,734 | ▼ 55.1% |
| Bills of exchange payable441 | - | - | - | €507 | - | - |
| Advances received on contracts in progress46 | - | - | €31,651 | €1,621 | - | - |
| Taxes, remuneration and social security45 | - | €163,672 | €117,602 | €141,522 | €202,773 | ▲ 43.3% |
| Taxes450/3 | - | €50,515 | €34,217 | €41,364 | €51,789 | ▲ 25.2% |
| Remuneration and social security454/9 | - | €113,157 | €83,385 | €100,159 | €150,984 | ▲ 50.7% |
| Other amounts payable47/48 | - | €165,374 | €284,073 | €243,019 | €45,504 | ▼ 81.3% |
| Accrued charges and deferred income492/3 | - | €6,253 | - | - | - | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €705,655 | €176,576 | €368,819 | €174,155 | €64,882 | ▼ 62.7% |
| + Depreciation and write-downs630 | €454 | €227 | €484 | €1,512 | €1,548 | ▲ 2.4% |
| Operating cash flow (approximation) | €706,109 | €176,803 | €369,303 | €175,667 | €66,430 | ▼ 62.2% |
| Investment in fixed assets (approximation) | - | -€800,000 | -€6,418 | €797,356 | €0 | ▼ 100% |
| Change in cash | - | -€1.5m | -€367,702 | -€84,573 | €109,310 | ▲ 229% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
03-08
State Gazette act
Resignations: MEULEMAN Philippe Charles Louis (director) and BERNARD Guy Ivan Marc (director)Appointment: AMARRIS HOLDING.BE (non-statutory director) · Permanent representative: ROBIN Claude Gilbert André · Reappointment: CDP PETIT & Co SRL (statutory auditor)20 facts ▸
- General meeting, 30-06-2026
- Other statement, première résolution - rapport spécial organe d’administration justification modification objet, sans réserves
- Purpose change
- Statutes amendment
- Other statement, inscription registre public ITAA, personne morale reconnue comme société d’expert-comptable certifié
- Capital
- Other statement, TITRE IV : ADMINISTRATION - CONTROLE, titre statutaire
- Director resignation, MEULEMAN Philippe Charles Louis (director)
- Director resignation, BERNARD Guy Ivan Marc (director)
- Director discharge, MEULEMAN Philippe Charles Louis
- Director discharge, BERNARD Guy Ivan Marc
- Board rule, 1
- +8 further facts in this act
About the unread acts
Of the 5 Belgian State Gazette acts we know for this company, 1 has been read. The other 4 have not been read yet: what they contain is neither established nor disproved here.
Directors · office · real estate
Board 1
Permanent representatives 1
Statutory auditor 1
Not every act has been read: a resignation may be missing here
1 establishment unit
1 parcel
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62817B0289/00P003 | Wallonia | 405 m² | 1 · 207 m² | 8.8 m · 3 fl. |
Linked by address, not proof of ownership
Mandate history
- Board
- Statutory auditor
- began earlier
| Name | Functions and periods |
|---|---|
| AMARRIS HOLDING.BE |
|
| CDP PETIT & Co |
|
| BERNARD Guy Ivan Marc |
|
| MEULEMAN Philippe Charles Louis |
|
Articles of association
Full purpose (12 activities)
- L'organisation de la comptabilité et des services comptables et les activités de conseil en matière d'organisation comptable des entreprises;
- La détermination des résultats et l'établissement des comptes annuels conformément aux dispositions légales en la matière;
- L'ouverture, la tenue, la centralisation et la clôture des écritures comptables propres à l'établissement des comptes;
- La vérification et le redressement de tous les documents comptables qui ne conduisent pas à une attestation ou un rapport d'expertise destinés à être remis à des tiers;
- L'analyse par les procédés de la technique comptable de la situation et du fonctionnement des entreprises du point de vue de leur crédit, de leur rendement et de leurs risques qui ne conduit pas à une attestation ou un rapport d'expertise destinés à être remis à des tiers;
- L'expertise, tant privée que judiciaire, dans le domaine de la comptabilité des entreprises;
- Toute mission visée aux 4° à 6° exercée par un expert-comptable certifié autre que le professionnel habituel qui conduit à une attestation ou un rapport d'expertise destinés à être remis à des tiers;
- Les autres missions dont l'accomplissement est réservé par la loi ou en vertu de la loi à l'expert-comptable certifié;
- La délivrance d'avis se rapportant à toutes matières fiscales;
- L'assistance du contribuable dans l'accomplissement de ses obligations fiscales;
- La représentation du contribuable auprès de l'administration fiscale;
- L'organisation des services administratifs et le conseil sur l'organisation administrative des entreprises.
Structure & network
Owners and holdings
1 ownerChain of control
- AMARRIS HOLDING.BE
- PHARMALEX
Highest known parent: AMARRIS HOLDING.BE. The sources do not say who stands above it.
Owners 1
-
100%
Holdings 0
No holding stated in the accounts, acts or LEI register we read.
According to the annual accounts of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
1 current directorThe network starts from this company’s directors. Other companies they run appear here as nodes.
Recognitions · licences · registrations
Legal Entity Identifier
Similar companies · same sector, comparable size
Identification & contact
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.